
Biography
Carol Kan is a Clinical Lecturer in Eating Disorders at the Institute of Psychiatry, Psychology & Neuroscience at King's College London.
Dr Kan graduated in medicine from University of Cambridge and Imperial College London. After completing her core psychiatric training at South London & Maudsley Trust, she was a BRC preparatory clinical fellow and then a Novo Nordisk UK Research Foundation clinical research fellow at the Institute of Psychiatry, Psychology & Neuroscience.
Her academic interests include genetic epidemiology, predictive modelling, psychedelics, depression, disordered eating and their relationships to physical health.
Research Interests
- Eating disorders
- Mood disorders
Research

kEtamine for the treatment of DEpression with anorexia Nervosa (EDEN)
The EDEN trial aims to investigate the effect of ketamine in alleviating depression with a diagnosis of persisting anorexia and treatment-resistant depression
Project status: Ongoing
News
£1.45million awarded for EDEN Project, a trial exploring ketamine for depression with anorexia nervosa
King’s researchers have been awarded the funds the MRC Developmental Pathway Funding Scheme to run a randomised controlled feasibility trial of oral ketamine...

Research

kEtamine for the treatment of DEpression with anorexia Nervosa (EDEN)
The EDEN trial aims to investigate the effect of ketamine in alleviating depression with a diagnosis of persisting anorexia and treatment-resistant depression
Project status: Ongoing
News
£1.45million awarded for EDEN Project, a trial exploring ketamine for depression with anorexia nervosa
King’s researchers have been awarded the funds the MRC Developmental Pathway Funding Scheme to run a randomised controlled feasibility trial of oral ketamine...
